Company Name
  • About Us
    • Company overview
    • Management Team
    • Board of Directors
    • Kinarus story
  • Programs and Pipeline
    • Therapeutic approach
    • Development Pipeline
  • Disease Areas
    • Age-Related Macular Degeneration
    • Covid-19
    • Idiopathic Pulmonary Fibrosis
  • Investors and Media
    • Stock Information
    • Financial News
    • Reports & Presentations
    • Financial Calendar
    • Corporate Governance
    • IR Contact & Service
  • Contact

  • Stock Information
    • Stock Quote and Chart
    • Listing Information
  • Analyst Coverage
  • Financial News
  • Webcast & Presentations
  • Financial Reporting
    • Annual Reports
    • Half Year Report
    • Perfect Holding SA – Historical Information
  • Corporate Governance
  • IR Contact & Service
Kinarus Therapeutics AG
Company research

Click on headlines below to download research

Implications of recent news flow

Kinarus Therapeutics | 03/01/2023
KINETIC study results

Kinarus Therapeutics | 30/09/2022
Making p38 MAP kinase inhibition viable

Kinarus Therapeutics | 07/09/2022

Kinarus Therapeutics AG
Technologiepark Basel
Hochbergerstrasse 60C
4057 Basel

+41 616332971
info@kinarus.com LinkedIn

Who we are
Kinarus Therapeutics AG is a biopharmaceutical company headquartered in Basel, Switzerland.

Links
Disclaimer Privacy policy Cookie policy Imprint